HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Facioscapulohumeral muscular dystrophy 1a

PROM
Also Known As:
FSHD1A; FSHMD1A; Facioscapulohumeral dystrophy with sensorineural hearing loss and tortuosity of retinal arterioles; Facioscapulohumeral muscular dystrophy, infantile; Landouzy-dejerine muscular dystrophy; Muscular dystrophy, facioscapulohumeral, type 1a
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Experts

1. MacKenzie, Jennifer J: 1 article (08/2014)
2. Piteau, Shalea J: 1 article (08/2014)
3. Rossiter, John P: 1 article (08/2014)
4. Smith, R Garth: 1 article (08/2014)
5. Hauerslev, S: 1 article (09/2013)
6. Hertz, J M: 1 article (09/2013)
7. Krag, T O: 1 article (09/2013)
8. Vissing, J: 1 article (09/2013)
9. Ørngreen, M C: 1 article (09/2013)
10. Ansseau, Eugénie: 1 article (08/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Facioscapulohumeral muscular dystrophy 1a:
1. Apoptosis Regulatory ProteinsIBA
2. Myosin Heavy Chains (Myosin Heavy Chain)IBA
3. VimentinIBA
4. EnzymesIBA
5. Mitochondrial DNA (mtDNA)IBA